Background: The host response to tissue injury requires a complex interplay of diverse cellular, humoral, and connective tissue elements. Fibroblasts participate in this process by proliferating within injured sites and contributing to scar formation and the longterm remodeling of damaged tissue. Fibroblasts present in areas of tissue injury generally have been regarded to arise by recruitment from surrounding connective tissue; however this may not be the only source of these cells.
INTRODUCTION
Wounds result from an abrupt, physical disruption of the normal architecture of tissue and may be produced by trauma, burns, inflammatory processes, or metabolic insufficiency. Once wounding occurs, the host initiates a coordinated repair response that prevents infection and tissue invasion and ultimately reestablishes normal tissue integrity. This response occurs over several phases and involves a complex interplay between cellular, humoral, and connective tissue elements (1) .
Connective tissue fibroblasts participate in the reparative phase of wound healing by producing matrix proteins, such as collagen, and forming a connective tissue scar. Over the long term, fibroblasts also act to remodel injured tis-sue, maintain tissue homeostasis, and ensure the long-term survival of connective tissue. Fibroblasts that enter and proliferate within wound sites generally have been regarded to arise from the recruitment and migration of cells from adjacent tissue. Under normal circumstances, these cells are quiescent and remain sparsely distributed throughout the extracellular matrix (2, 3) .
A frequently employed model for the study of wound healing responses relies on the surgical implantation of wound chambers that consist of short lengths of sponge-filled, silastic tubing (4) . Implantation of these chambers into the subcutaneous tissues of mice results within 24 hr in a rapid influx of peripheral blood cells comprising neutrophil, monocyte, and lymphocyte subpopulations (4, 5) . While studying acute cellular responses in this model of wound repair, we observed by light microscopy an unexpectedly large number of adherent, spindle-shaped cells that resembled fibroblasts. The appearance of fiCopyright ) 1994, Molecular Medicine 71 broblasts in wound chambers has been attributed to their recruitment from surrounding subcutaneous tissue (1) (2) (3) . Therefore, the presence of large numbers of fibroblast-like cells coincidentally with the entry of circulating inflammatory cells suggested to us that this cell population was arising from peripheral blood and not exclusively by slow migration from adjacent connective tissue. We describe herein the isolation and cell surface phenotype of this apparently novel, blood-borne, fibroblast-like cell. This cell type, which we have termed a fibrocyte, was found to enter sites of tissue injury and to contribute to connective tissue scar formation. Bone Marrow Chimera Studies Female (BALB/c) mice were lethally irradiated (800 rads) and reconstituted intravenously with 106 bone marrow cells harvested from the femurs of male (BALB/c) mice (7) . Wound chambers were implanted into mice 6 TGGCCCAGCAGAAT-3' and 3'-TATAGTCGGAG TAGCCTC-5') (8) amplify a 143 bp genomic DNA fragment, and the f3-actin primers (5'-GTGGG CCGCTCTAGGCACC-3' and 3'-CCCCCTGAACC CCTAAGGCCA-5') (9) amplify a 241 bp genomic DNA segment. Ten microliters of reaction products were analyzed by gel electrophoreses in 2% agarose gels containing 100 ng/ml of ethidium bromide.
MATERIALS AND METHODS

RESULTS
In preliminary studies performed in mice, we observed that a large proportion of cells aspirated within 2 days of wound chamber implantation showed an adherent, spindle-shaped phenotype that was reminiscent of cultured primary fibroblasts. Further analyses demonstrated these cells to stain strongly for the fibroblast markers collagen I and vimentin and to be negative for nonspecific esterases, indicating that these cells were phenotypically distinct from the numerically larger copopulation of adherent, peripheral blood monocytes. We considered that any fibroblast-like cells present in circulation would be likely to comprise only a small fraction of peripheral blood cells and thus turned to an examination of human blood (available in greater quantities) for the identification of circulating fibroblast-like cell types.
Total leukocyte fractions were isolated from peripheral blood by Ficoll centrifugation and cultured in serum-supplemented DMEM under conditions selective for the ability of connective tissue cells to adhere to plastic surfaces and proliferate. As expected, there was a slow decline in the nonproliferating monocyte cell population over a 2-4 week period. This was accompanied by the emergence of expanding clusters of adherent cells that gradually increased in number. Light microscopy showed this proliferating cell type (henceforth termed a fibrocyte) to display a largely fibroblast-like, spindle-shaped morphology (Fig. la) . Staining for nonspecific esterases was not observed, indicating that fibrocytes were not derived from monocyte/macrophages (data not shown). Furthermore, there was positive staining for the fibroblast cytoskeletal component vimentin and for collagen I (10, 11) (Fig.  lb) . Scanning electron microscopy showed these cells to be morphologically distinct from circulating blood leukocytes and to display prominent CD45 and the hematopoietic stem cell antigen CD34 (13) (14) (15) . The CD34 antigen was identified originally to be a marker of bone marrow progenitor cells but has been reported recently to be expressed also by capillary endothelium and by embryonic fibroblasts (16, 17) . We hypothesized that the CD34+, vimentin+, collagen 1+ fibrocytes isolated from peripheral blood represent a circulating population of uncommitted (or incompletely differentiated) fibroblast precursors that are conceivably of bone marrow origin.
Using immunofluorescence "spot" staining, we then examined the time-dependent appearance of CD34+, collagen I+ cells in cultures prepared from human peripheral blood (Fig. 3) (Fig. 4) . Double immunofluorescence analysis showed that over 10 days, 10 To assess more directly the role of circulating fibrocytes in wound repair, we next examined scar tissue obtained from wound chambers that had been implanted in mice for a period of 7-56 days. The chambers were removed, examined histologically, and analyzed for reactivity with monoclonal anti-CD34 antibody or an isotypematched antibody control (Fig. 6a) . CD34+ cells exhibiting fibroblast morphology were readily identified in areas of scarring and connective tissue cell proliferation. In addition, progressively more anti-CD34 staining (and fibrosis) was observed with increasing time after implantation. We then examined cutaneous, connective tissue scars obtained from mice for the presence of CD34 expression. Skin was removed from mice 28 days after an experimentally induced, surgical incision and stained with monoclonal anti-CD34 antibody. As shown in Fig. 6b , areas of connective tissue scar and cellular proliferation were markedly positive for CD34.
Finally, we examined cutaneous scar tissue obtained from a human subject at autopsy. Positive staining for CD34 was observed within the subcutaneous regions of human scar but not in sections obtained from control, nonscarred skin (Figs. 7a-7e ). (3, 20 
